N2-Tritylolmesartan medoxomil is a trityl-protected intermediate in the synthesis of olmesartan medoxomil, an angiotensin II receptor antagonist. Its structure incorporates a triphenylmethyl (trityl) protecting group on the tetrazole ring, which is later removed to yield the active pharmaceutical ingredient.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1020157-01-0
Tritylolmesartan medoxomil
pharmaceutical intermediate
N-Trityl Olmesartan Ethyl Ester
pharmaceutical intermediate
Olmesartan medoxomil
pharmaceutical raw material
2-(4-Biphenylyl)-4,6-dichloro-1,3,5-triazine
research compound
3,5-Dichlorobenzaldehyde
chemical intermediate for research
2-(3-methoxyphenyl)-1,1-dioxo-2H-1??-thieno(3,2-e)(1,2)thiazine-6-sulfonamide
Research compound
2,3-dimethoxy-7,7-dimethyl-9-trifluoromethyl-7H-benzo[C]fluoren-5-ol
research chemical
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
KKYFOXOGKNDKRS-UHFFFAOYSA-N
CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN(N=N4)C(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)C(=O)OCC8=C(OC(=O)O8)C)C(C)(C)O